CEoT 2022
Scottsdale, Arizona, USA
Postponed Until Further Notice
The event organizers announced that after careful consideration, this event will be moving forward as a virtual event on April 6-8, 2022
Registered to attend CEOT? Don't miss our Breakfast Symposium. Join us for a talk on gene expression profiling for the clinical care of heart and kidney transplant patients.
One Lambda Agenda at CEoT
Friday, February 18
7:45 – 9:00 am GMT
CEOT 2022 BREAKFAST SYMPOSIUM
The Clinical Utility of Allograft Gene Expression Profiling for Heart and Kidney Biopsies
Moderator:
Christopher Lawrence, MD – Sr. Director of Medical Affairs | Thermo Fisher Scientific
Presentations:
Value of MMDx In Diagnostic Uncertainty in Patients with Heart Transplantation: Case Based Presentation
A case-based presentation that explores the clinical implementation of MMDx Heart in conjunction with traditional histopathology.
Ashrith Guha, MD – Houston Methodist, Houston, TX
MMDx Across the Lifespan: Transition of Care from Pediatric to Adult in Kidney Transplantation
A discussion on how MMDx Kidney can be used and applied across the lifespan of a kidney transplant patient, including managing the transition from pediatric to adult care.
Rita Swinford, MD – Hermann Memorial, Houston, TX
Aleksandra De Golovine, MD– Hermann Memorial, Houston, TX
Our participation at this event is subject to change with our without notice.
Share This Page
